Effect of metformin vs placebo on invasive disease–free survival in patients with breast cancer: the MA. 32 randomized clinical trial

PJ Goodwin, BE Chen, KA Gelmon, TJ Whelan… - Jama, 2022 - jamanetwork.com
Importance Metformin, a biguanide commonly used to treat type 2 diabetes, has been
associated with potential beneficial effects across breast cancer subtypes in observational …
被引用次数：136 相关文章

Effect of Metformin vs Placebo on Invasive Disease-Free Survival in Patients With Breast Cancer: The MA. 32 Randomized Clinical Trial

PJ Goodwin, BE Chen, KA Gelmon, TJ Whelan… - …, 2022 - pubmed.ncbi.nlm.nih.gov
Importance Metformin, a biguanide commonly used to treat type 2 diabetes, has been
associated with potential beneficial effects across breast cancer subtypes in observational …

Effect of Metformin vs Placebo on Invasive Disease-Free Survival in Patients With Breast Cancer: The MA. 32 Randomized Clinical Trial.

PJ Goodwin, BE Chen, KA Gelmon, TJ Whelan… - JAMA, 2022 - europepmc.org
Effect of Metformin vs Placebo on Invasive Disease-Free Survival in Patients With Breast
Cancer: The MA.32 Randomized Clinical Trial. - Abstract - Europe PMC Sign in | Create an …

Effect of Metformin vs Placebo on Invasive Disease-Free Survival in Patients With Breast Cancer: The MA. 32 Randomized Clinical Trial.

PJ Goodwin, BE Chen, KA Gelmon… - JAMA: the journal of …, 2022 - boris.unibe.ch
Importance Metformin, a biguanide commonly used to treat type 2 diabetes, has been
associated with potential beneficial effects across breast cancer subtypes in observational …

Effect of Metformin vs Placebo on Invasive Disease-Free Survival in Patients With Breast Cancer: The MA. 32 Randomized Clinical Trial.

PJ Goodwin, BE Chen, KA Gelmon… - JAMA: Journal of …, 2022 - search.ebscohost.com
Abstract < bold> Importance: </bold> Metformin, a biguanide commonly used to
treat type 2 diabetes, has been associated with potential beneficial effects across breast …
[HTML] nih.gov

[HTML][HTML] Effect of Metformin vs Placebo on Invasive Disease–Free Survival in Patients With Breast Cancer: The MA. 32 Randomized Clinical Trial

PJ Goodwin, BE Chen, KA Gelmon, TJ Whelan… - JAMA, 2022 - ncbi.nlm.nih.gov
Effect of Metformin vs Placebo on Invasive Disease–Free Survival in Patients With Breast
Cancer - PMC Back to Top Skip to main content NIH NLM Logo Access keys NCBI Homepage …
[PDF] yuntsg.com

[PDF][PDF] Effect of Metformin vs Placebo on Invasive Disease–Free Survival in Patients With Breast Cancer The MA. 32 Randomized Clinical Trial

PJ Goodwin, BE Chen, KA Gelmon, TJ Whelan… - JAMA, 2022 - bookcafe.yuntsg.com
OBJECTIVE To determine whether the administration of adjuvant metformin (vs placebo) to
patients with breast cancer without diabetes improves outcomes. DESIGN, SETTING, AND …
[HTML] birmingham.ac.uk

[HTML][HTML] Effect of metformin vs placebo on invasive disease-free survival in patients with breast cancer: the MA. 32 randomized clinical trial

PJ Goodwin, BE Chen, KA Gelmon… - JAMA The Journal …, 2022 - research.birmingham.ac.uk
Importance: Metformin, a biguanide commonly used to treat type 2 diabetes, has been
associated with potential beneficial effects across breast cancer subtypes in observational …

Effect of Metformin vs Placebo on Invasive Disease-Free Survival in Patients with Breast Cancer: The MA. 32 Randomized Clinical Trial

PJ Goodwin, BE Chen, KA Gelmon, TJ Whelan… - …, 2022 - mayoclinic.elsevierpure.com
Importance: Metformin, a biguanide commonly used to treat type 2 diabetes, has been
associated with potential beneficial effects across breast cancer subtypes in observational …

Effect of Metformin vs Placebo on Invasive Disease-Free Survival in Patients With Breast Cancer: The MA. 32 Randomized Clinical Trial.

PJ Goodwin, BE Chen, KA Gelmon… - JAMA: Journal of the …, 2022 - repository.icr.ac.uk
IMPORTANCE: Metformin, a biguanide commonly used to treat type 2 diabetes, has been
associated with potential beneficial effects across breast cancer subtypes in observational …